Lilly and Boehringer roll toward EU approval with diabetes combo

Damian Garde

Eli and Ingelheim secured a recommendation from European regulators for their combination treatment, making for a likely continental in the coming months.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS